Systemic Delivery of Tyrosine-Mutant AAV Vectors Results in Robust Transduction of Neurons in Adult Mice
Recombinant adeno-associated virus (AAV) vectors are powerful tools for both basic neuroscience experiments and clinical gene therapies for neurological diseases. Intravascularly administered self-complementary AAV9 vectors can cross the blood-brain barrier. However, AAV9 vectors are of limited usef...
Main Authors: | Asako Iida, Naomi Takino, Hitomi Miyauchi, Kuniko Shimazaki, Shin-ichi Muramatsu |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2013-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2013/974819 |
Similar Items
-
Syngeneic AAV Pseudo-particles Potentiate Gene Transduction of AAV Vectors
by: Qizhao Wang, et al.
Published: (2017-03-01) -
Successful Transduction with AAV Vectors after Selective Depletion of Anti-AAV Antibodies by Immunoadsorption
by: Alejandro Orlowski, et al.
Published: (2020-03-01) -
Systemic gene transfer reveals distinctive muscle transduction profile of tyrosine mutant AAV-1, -6, and -9 in neonatal dogs
by: Chady H Hakim, et al.
Published: (2014-01-01) -
Robust Long-term Transduction of Common Marmoset Neuromuscular Tissue With rAAV1 and rAAV9
by: Hironori Okada, et al.
Published: (2013-01-01) -
Role of Essential Metal Ions in AAV Vector-Mediated Transduction
by: Himanshu K. Rambhai, et al.
Published: (2020-09-01)